Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Weiner

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Alzheimer'S Disease : JAD|August 13, 2014
A candidate plasma protein classifier to identify Alzheimer's diseaseXuemei Zhao, Serguei Lejnine, Jeffrey Spond, et al.
Archives of Pathology & Laboratory Medicine|October 28, 2016
Development of a Prototype Immunohistochemistry Assay to Measure Programmed Death Ligand-1 Expression in Tumor TissueMarisa Dolled-Filhart, Darren Locke, Tiffany Murphy, et al.
The AAPS Journal|April 22, 2009
Workshop report and follow-up--AAPS Workshop on current topics in GLP bioanalysis: Assay reproducibility for incurred samples--implications of Crystal City recommendationsDouglas M Fast, Marian Kelley, C T Viswanathan, et al.
Pharmaceutical Research|April 27, 2007
Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assaysC T Viswanathan, Surendra Bansal, Brian Booth, et al.
Bioanalysis|April 1, 2015
A clinical biomarker assay to quantitate thymic stromal lymphopoietin in human plasma at sub-pg/ml levelXuemei Zhao, Gulesi Ayanoglu, Melissa Bilardello, et al.
Analytical and Bioanalytical Chemistry|December 2, 2011
Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodiesShujie J Wang, Steven T Wu, Jochem Gokemeijer, et al.
The AAPS Journal|January 1, 2015
Workshop report: Crystal City V--quantitative bioanalytical method validation and implementation: the 2013 revised FDA guidanceBrian Booth, Mark E Arnold, Binodh DeSilva, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2016
Prognostic Significance of PD-L1 in Patients with Non-Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected CasesJong-Mu Sun, Wei Zhou, Yoon-La Choi, et al.
Pharmaceutical Research|January 7, 2006
Fit-for-purpose method development and validation for successful biomarker measurementJean W Lee, Viswanath Devanarayan, Yu Chen Barrett, et al.
Pharmaceutical Research|September 1, 2005
Bioanalytical method validation for macromolecules in support of pharmacokinetic studiesJoMarie Smolec, Binodh DeSilva, Wendell Smith, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Alzheimer'S Disease : JAD|August 13, 2014
A candidate plasma protein classifier to identify Alzheimer's diseaseXuemei Zhao, Serguei Lejnine, Jeffrey Spond, et al.
Archives of Pathology & Laboratory Medicine|October 28, 2016
Development of a Prototype Immunohistochemistry Assay to Measure Programmed Death Ligand-1 Expression in Tumor TissueMarisa Dolled-Filhart, Darren Locke, Tiffany Murphy, et al.
The AAPS Journal|April 22, 2009
Workshop report and follow-up--AAPS Workshop on current topics in GLP bioanalysis: Assay reproducibility for incurred samples--implications of Crystal City recommendationsDouglas M Fast, Marian Kelley, C T Viswanathan, et al.
Pharmaceutical Research|April 27, 2007
Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assaysC T Viswanathan, Surendra Bansal, Brian Booth, et al.
Bioanalysis|April 1, 2015
A clinical biomarker assay to quantitate thymic stromal lymphopoietin in human plasma at sub-pg/ml levelXuemei Zhao, Gulesi Ayanoglu, Melissa Bilardello, et al.
Analytical and Bioanalytical Chemistry|December 2, 2011
Attribution of the discrepancy between ELISA and LC-MS/MS assay results of a PEGylated scaffold protein in post-dose monkey plasma samples due to the presence of anti-drug antibodiesShujie J Wang, Steven T Wu, Jochem Gokemeijer, et al.
The AAPS Journal|January 1, 2015
Workshop report: Crystal City V--quantitative bioanalytical method validation and implementation: the 2013 revised FDA guidanceBrian Booth, Mark E Arnold, Binodh DeSilva, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2016
Prognostic Significance of PD-L1 in Patients with Non-Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected CasesJong-Mu Sun, Wei Zhou, Yoon-La Choi, et al.
Pharmaceutical Research|January 7, 2006
Fit-for-purpose method development and validation for successful biomarker measurementJean W Lee, Viswanath Devanarayan, Yu Chen Barrett, et al.
Pharmaceutical Research|September 1, 2005
Bioanalytical method validation for macromolecules in support of pharmacokinetic studiesJoMarie Smolec, Binodh DeSilva, Wendell Smith, et al.
Pageof 3